IMS Health Cuts Pharma Growth Forecast
Big Pharma isn't so immune to the recession after all. In an indication the deterioration of the global economy is hitting drugmakers, a research group said on Apr. 22 that it's cutting a closely watched forecast for industry growth.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.